inflammation and glp-1 Incretins as Multi–Disease State Treatments Do GLP-1 drugs reduce inflammation?

GLP-1RAs in nervous system In the nervous system, GLP-1 can decrease oxidative stress and inflammatory responses, potentially through reducing the generation of ROS and decreasing the expression of inflammatory cytokines

For example, participants in the trials reported side effects that were generally consistent with previous studies, such as gastrointestinal symptoms, which are one of the main reasons that can lead to discontinuation of the drugs

It's a known, predictable physiological response

Interestingly, studies have shown that patients with MUP may have improved survival compared with melanoma of a known primary